199 related articles for article (PubMed ID: 33003279)
1. First Evidence of Kv3.1b Potassium Channel Subtype Expression during Neuronal Serotonergic 1C11 Cell Line Development.
Tabka H; Cheikh A; Maatoug S; Ayeb ME; Bendahhou S; Benkhalifa R
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33003279
[TBL] [Abstract][Full Text] [Related]
2. Open channel block of Kv3.1 currents by fluoxetine.
Sung MJ; Ahn HS; Hahn SJ; Choi BH
J Pharmacol Sci; 2008 Jan; 106(1):38-45. PubMed ID: 18187934
[TBL] [Abstract][Full Text] [Related]
3. Effects of norfluoxetine, the major metabolite of fluoxetine, on the cloned neuronal potassium channel Kv3.1.
Choi BH; Choi JS; Yoon SH; Rhie DJ; Min DS; Jo YH; Kim MS; Hahn SJ
Neuropharmacology; 2001 Sep; 41(4):443-53. PubMed ID: 11543764
[TBL] [Abstract][Full Text] [Related]
4. Potential role for kv3.1b channels as oxygen sensors.
Osipenko ON; Tate RJ; Gurney AM
Circ Res; 2000 Mar; 86(5):534-40. PubMed ID: 10720415
[TBL] [Abstract][Full Text] [Related]
5. Complex N-Glycans Influence the Spatial Arrangement of Voltage Gated Potassium Channels in Membranes of Neuronal-Derived Cells.
Hall MK; Weidner DA; Edwards MA; Schwalbe RA
PLoS One; 2015; 10(9):e0137138. PubMed ID: 26348848
[TBL] [Abstract][Full Text] [Related]
6. Increase of Kv3.1b expression in avian auditory brainstem neurons correlates with synaptogenesis in vivo and in vitro.
Kuenzel T; Wirth MJ; Luksch H; Wagner H; Mey J
Brain Res; 2009 Dec; 1302():64-75. PubMed ID: 19766604
[TBL] [Abstract][Full Text] [Related]
7. FLUOXETINE modifies the expression of serotonergic markers in a differentiation-dependent fashion in the mesencephalic neural cell line A1 mes c-myc.
Di Lieto A; Leo D; Volpicelli F; di Porzio U; Colucci-D'Amato L
Brain Res; 2007 Apr; 1143():1-10. PubMed ID: 17321503
[TBL] [Abstract][Full Text] [Related]
8. N-Linked glycan site occupancy impacts the distribution of a potassium channel in the cell body and outgrowths of neuronal-derived cells.
Hall MK; Weidner DA; Bernetski CJ; Schwalbe RA
Biochim Biophys Acta; 2014 Jan; 1840(1):595-604. PubMed ID: 24161696
[TBL] [Abstract][Full Text] [Related]
9. Understanding the molecular pharmacology of the serotonergic system: using fluoxetine as a model.
Sghendo L; Mifsud J
J Pharm Pharmacol; 2012 Mar; 64(3):317-25. PubMed ID: 22309263
[TBL] [Abstract][Full Text] [Related]
10. Adolescence fluoxetine increases serotonergic activity in the raphe-hippocampus axis and improves depression-like behaviors in female rats that experienced neonatal maternal separation.
Yoo SB; Kim BT; Kim JY; Ryu V; Kang DW; Lee JH; Jahng JW
Psychoneuroendocrinology; 2013 Jun; 38(6):777-88. PubMed ID: 23010142
[TBL] [Abstract][Full Text] [Related]
11. Kv3.1b is a novel component of CNS nodes.
Devaux J; Alcaraz G; Grinspan J; Bennett V; Joho R; Crest M; Scherer SS
J Neurosci; 2003 Jun; 23(11):4509-18. PubMed ID: 12805291
[TBL] [Abstract][Full Text] [Related]
12. Effect of psoralen on the cloned Kv3.1 currents.
Sung MJ; Hahn SJ; Choi BH
Arch Pharm Res; 2009 Mar; 32(3):407-12. PubMed ID: 19387585
[TBL] [Abstract][Full Text] [Related]
13. Developmental changes in the expression of calbindin and potassium-channel subunits Kv3.1b and Kv3.2 in mouse Renshaw cells.
Song ZM; Hu J; Rudy B; Redman SJ
Neuroscience; 2006 May; 139(2):531-8. PubMed ID: 16460880
[TBL] [Abstract][Full Text] [Related]
14. The comparative effects of environmental enrichment with exercise and serotonin transporter blockade on serotonergic neurons in the dorsal raphe nucleus.
MacGillivray L; Reynolds KB; Rosebush PI; Mazurek MF
Synapse; 2012 May; 66(5):465-70. PubMed ID: 22121041
[TBL] [Abstract][Full Text] [Related]
15. Modulation of Kv3.1b potassium channel phosphorylation in auditory neurons by conventional and novel protein kinase C isozymes.
Song P; Kaczmarek LK
J Biol Chem; 2006 Jun; 281(22):15582-91. PubMed ID: 16595659
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of Kv3.1b and Kv3.2 potassium channel subunits in interneurons of the basolateral amygdala.
McDonald AJ; Mascagni F
Neuroscience; 2006; 138(2):537-47. PubMed ID: 16413129
[TBL] [Abstract][Full Text] [Related]
17. Effect of selective serotonin reuptake inhibitors via 5-HT1A receptors on L-DOPA-induced rotational behavior in a hemiparkinsonian rat model.
Inden M; Abe M; Minamino H; Takata K; Yoshimoto K; Tooyama I; Kitamura Y
J Pharmacol Sci; 2012; 119(1):10-9. PubMed ID: 22510520
[TBL] [Abstract][Full Text] [Related]
18. Robust presynaptic serotonin 5-HT(1B) receptor inhibition of the striatonigral output and its sensitization by chronic fluoxetine treatment.
Ding S; Li L; Zhou FM
J Neurophysiol; 2015 May; 113(9):3397-409. PubMed ID: 25787955
[TBL] [Abstract][Full Text] [Related]
19. The role of 5-HT(1A) and 5-HT(1B/1D) receptors on the modulation of acute fluoxetine-induced changes in extracellular 5-HT: the mechanism of action of (+/-)pindolol.
Dawson LA; Nguyen HQ
Neuropharmacology; 2000 Apr; 39(6):1044-52. PubMed ID: 10727715
[TBL] [Abstract][Full Text] [Related]
20. Forced swimming test and fluoxetine treatment: in vivo evidence that peripheral 5-HT in rat platelet-rich plasma mirrors cerebral extracellular 5-HT levels, whilst 5-HT in isolated platelets mirrors neuronal 5-HT changes.
Bianchi M; Moser C; Lazzarini C; Vecchiato E; Crespi F
Exp Brain Res; 2002 Mar; 143(2):191-7. PubMed ID: 11880895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
